A proposal of criteria for the classification of systemic sclerosis

Medical Science Monitor

Volumn 10, Issue 11, 2004, Pages

  Nadashkevich, Oleg ^a   Davis, Paul ^b   Fritzler, Marvin J ^c,d  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti centromere proteins antibodies; Anti fibrillarin antibodies; Anti Scl 70 (topo I) antibodies; Classification criteria; Scleroderma; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CELL PROTEIN; CENTROMERE PROTEIN; CENTROMERE PROTEIN ANTIBODY; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; FIBRILLARIN; FIBRILLARIN ANTIBODY; LA ANTIGEN; PROTEIN ANTIBODY; RIBONUCLEOPROTEIN; RO ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CANADA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; EUROPE; HUMAN; JOINT CONTRACTURE; LABORATORY DIAGNOSIS; LUNG FIBROSIS; MAJOR CLINICAL STUDY; OSTEOLYSIS; RAYNAUD PHENOMENON; REFLUX ESOPHAGITIS; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SKIN CALCIFICATION; SYNDROME CREST; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VALIDATION PROCESS;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; SCLERODERMA, SYSTEMIC;

EID: 9144228790     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum,984; 27: 361-68
2. Fries JF, Hochberg MC, Medsger TA Jr et al: Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum, 1994; 37: 454-62
3. Vitali C, Bombardieri S, Jonsson R et al: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002; 61: 554-58
4. Masi AT, Rodnan GP, Medsger T Jr et al: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum, 1980: 23: 581-90
5. Wigley FM: Systemic sclerosis: clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology. Philadelphia, Mosby, 1998; 7.9.1-7.9.13
6. Medsger TA Jr: Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR, editors. Current topics in rheumatology: sytemic sclerosis (scleroderma). New York, Cower Medical Publishing, 1985;16-17
7. LeRoy EC, Black C, Fleischmajer R et al: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol, 1988; 15: 202-5
8. Masi AT: Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol, 1988; 15: 894-98
9. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr: Systemic sclerosis sine scleroderma - Demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum, 2000; 43: 444-51
10. Lonzetti LS, Joyal F, Raynauld JP et al: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum, 2001; 44: 735-36
11. Seibold JR: Scleroderma and mixed connective tissue diseases. In: Ruddy S, Harris ED Jr, Sledge CB, editors. Kelley's Textbook of Rheumatology. Philadelphia, W.B. Saunders, 2001; 1211-39
12. LeRoy EC, Medsger TA Jr: Criteria for the classification of early systemic sclerosis. J Rheumatol, 2001; 28: 1573-76
13. Mitri GM, Lucas M, Fertig N et al: A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum, 2003; 48: 203-9
14. Barnett AJ, Miller MH, Littlejohn GO: A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol, 1988; 15: 276-83
15. Mast AT, Medsger TA Jr, Rodnan GP et al: Methods and preliminary results of the scleroderma criteria cooperative study of the American Rheumatism Association. Clin Rheum Dis, 1979; 5: 27-48
16. Masi AT, Rodnan GP, Medsger TA Jr et al: Preliminary criteria for the classification of systemic sclerosis (Scleroderma). Bull Rheum Dis, 1981; 31: 1-6
17. Rodnan GP: Progressive systemic sclerosis. In: McCarty DJ Jr, editor. Arthritis and allied conditions. Philadelphia: Lea & Febiger, 1979: 762-809
18. Barnett AJ, Miller M, Littlejohn GO: The diagnosis and classification of scleroderma (systemic sclerosis). Postgrad Med J, 1988; 64: 121-25
19. Tan EM, Cohen AS, Fries JF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982; 25: 1271-77
20. Arnett FC, Edworthy SM, Bloch DA et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988: 31: 315-24
21. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 1975; 292: 344-47
22. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med, 1975; 292: 403-7
23. Fox RI, Robinson CA, Curd JG et al: Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum, 1986; 29: 577-85
24. Allen EV, Brown GE: Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med, 1932; 183: 187-200
25. Fritzler MJ: Autoantibody testing: Procedures and significance in systemic rheumatic diseases. Meth Achiev Exp Pathol, 1986; 12: 224-60
26. Wilson MR, Sanders RD: Immunodiffusion assays for antibodies to small nuclear ribonucleoproteins and other cellular antigens. In: Rose NR, de Macario EC, Fahey JL, Friedman H, Penn GM, editors. Manual of Clinical Laboratory Immunology. Washington: American Society for Microbiology, 1992: 741-46
27. Arnett FC, Reveille JD, Goldstein R et al: Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): An immunogenetic, serological and clinical analysis. Arthritis Rheum, 1996; 39: 1151-60
28. Kasukawa R, Tojo T, Miayawaki S: Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam, Excerpta Medica, 1987; 41-47
29. Black CM, Denton CP: The management of systemic sclerosis. Br J Rheumatol, 1995; 34: 3-7
30. Frieder MJ, Tan EM: Antinuclear antibodies and the connective tissue diseases. In: Cohen AS, editor. Laboratory diagnostic procedures in the rheumatic diseases. New York, Grune and Stratton, 1985: 207-47
31. Matucci-Cerinic M, D'Angelo S, Denton CP et al: Assessment of lung involvement. Clin Exp Rheumatol, 2003; 21: S19-S23
32. Moore G: Atlas of the musculosceletal examination. Philadelphia: Versa Press, 2003
33. Palmer DG, Hale GM, Grennan DM, Pollock M: Bowed fingers. A helpful sign in the early diagnosis of systemic sclerosis. J Rheumatol, 1981; 8: 266-72
34. Clements P, Lachenbruch P, Siebold J et al: Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol, 1995; 22: 1281-85
35. Decker JL, Esdaile JM, Fritzler MJ et al: Dictionary of the Rheumatic Diseases. In: American Rheumatism Association Glossary Committee, editor. New York, Contact Associates, 1982
36. Fritzler MJ: Autoantibodies in scleroderma. J Dermatol, 1993; 20: 257-68
37. Steen VD, Powell DL, Medsger TA Jr: Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum, 1988; 31: 196-203
38. Okano Y, Steen VD, Medsger TA: Serum autoantibodies reactive with RNA polymerase III (RNP3), a major autoantigen in systemic sclerosis (SSc) with diffuse cutaneous involvement. Arthritis Rheum (abstract), 1992; 35(9S): S38
39. Okano Y: Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin NA, 1996; 22: 709-35
40. Lee P, Sarkozi J, Bookman AA et al: Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon. J Rheumatol, 1986; 13: 564-69
41. Monticone G, Colonna L, Palermi G et al: Quantitative nailfold capillary microscopy findings in patients with acrocyanosis compared with patients having systemic sclerosis and control subjects. J Am Acad Dermatol, 2000; 42: 787-90
42. Bredemeier M, Xavier RM, Capobianco KG et al: Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol, 2004; 31: 286-94
43. McHugh NJ, Distler O, Giacomelli R, Riemekasten G: Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol, 2003; 21: S32-S38
44. Sule SD, Wigley FM: Treatment of scleroderma: an update. Expert Opin Investig Drugs, 2003; 12: 471-82
45. Myers AR: Progressive systemic sclerosis: gastrointestinal involvement. Clin Rheum Dis, 1979; 5: 115-29